Two Bundibugyo‑Targeted Ebola Vaccines to Begin Phase‑2 Trials in DRC
Oxford‑Moderna and Oxford‑Serum Institute candidates will start Phase‑2 testing in Bunia next week, marking a key step against the Bundibugyo Ebola strain.
Oxford‑Moderna and Oxford‑Serum Institute candidates will start Phase‑2 testing in Bunia next week, marking a key step against the Bundibugyo Ebola strain.